Targeted therapy for ovarian cancer
Targeted therapy is a newer type of cancer treatment that uses drugs or other substances to find and attack cancer cells while doing little damage to normal cells. Each type of targeted therapy works differently, but all change the way a cancer cell grows, divides, repairs itself, or acts.
Bevacizumab (Avastin®) is a targeted drug that helps block the formation of new blood vessels. It can be combined with chemotherapy to treat advanced ovarian cancer.
Olaparib (Lynparza™) helps kill cells by affecting DNA repair. Because of the way it works, it is only an option for women who have abnormal changes (mutations) in either BRCA1 or BRCA2.
For more information about the use of these drugs for ovarian cancer, see the more detailed information in out document Ovarian Cancer.
Studies of other targeted therapy drugs that could be used for ovarian cancer are going on now.
Last Medical Review: 08/08/2014
Last Revised: 01/26/2015